Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K30 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S38 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S38 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K128 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K128 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S136 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K143 P16615 488 ATP2A2 ATP2B Brain lower grade glioma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Kidney renal clear cell carcinoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Brain lower grade glioma Methylation N R164 P16615 488 ATP2A2 ATP2B Keratosis follicularis Methylation N R164 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Methylation N R164 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K169 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S178 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N S178 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S186 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K189 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Head and neck squamous cell carcinoma Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K205 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S210 P16615 488 ATP2A2 ATP2B Darier disease Acetylation N K218 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Global developmental delay Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Global developmental delay Phosphorylation N T230 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N T242 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K252 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K252 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S261 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N Y294 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Thyroid carcinoma Ubiquitination N K400 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y407 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K436 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T441 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K451 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma SUMOylation N K480 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Acetylation N K481 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Ubiquitination N K481 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Phosphorylation N T484 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N T484 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Phosphorylation N S488 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S488 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S495 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y497 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N Y497 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T499 P16615 488 ATP2A2 ATP2B Urinary bladder cancer Phosphorylation N S531 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S538 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K541 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K543 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S546 P16615 488 ATP2A2 ATP2B Keratosis follicularis Methylation N R549 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S553 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S555 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S555 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Breast invasive carcinoma SUMOylation N K585 P16615 488 ATP2A2 ATP2B Darier disease SUMOylation N K585 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S608 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S608 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S663 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K685 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K711 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S740 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T741 P16615 488 ATP2A2 ATP2B Lung squamous cell carcinoma Acetylation N K757 P16615 488 ATP2A2 ATP2B Lung squamous cell carcinoma Ubiquitination N K757 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y836 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S973 P49116 7182 NR2C2 TAK1 TR4 Stomach adenocarcinoma Phosphorylation N S12 P49116 7182 NR2C2 TAK1 TR4 Stomach adenocarcinoma Phosphorylation N T13 P49116 7182 NR2C2 TAK1 TR4 Breast cancer Phosphorylation N S68 P49116 7182 NR2C2 TAK1 TR4 Colon adenocarcinoma Phosphorylation N S98 P49116 7182 NR2C2 TAK1 TR4 Skin cutaneous melanoma Phosphorylation N S98 P49116 7182 NR2C2 TAK1 TR4 Bladder urothelial carcinoma Phosphorylation N S219 P49116 7182 NR2C2 TAK1 TR4 Bladder urothelial carcinoma Phosphorylation N T224 P49116 7182 NR2C2 TAK1 TR4 Renal cell carcinoma Phosphorylation N S328 P49116 7182 NR2C2 TAK1 TR4 Renal cell carcinoma Phosphorylation N S330 P49116 7182 NR2C2 TAK1 TR4 Adrenocortical carcinoma Phosphorylation N S351 P49116 7182 NR2C2 TAK1 TR4 Adrenocortical carcinoma Phosphorylation N T352 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Phosphorylation N S11 Q15750 10454 TAB1 MAP3K7IP1 Adrenocortical carcinoma Phosphorylation N S16 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Phosphorylation N S16 Q15750 10454 TAB1 MAP3K7IP1 Kidney renal clear cell carcinoma Ubiquitination N K42 Q15750 10454 TAB1 MAP3K7IP1 Skin cutaneous melanoma Ubiquitination N K42 Q15750 10454 TAB1 MAP3K7IP1 Stomach adenocarcinoma Ubiquitination N K150 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Ubiquitination N K192 Q15750 10454 TAB1 MAP3K7IP1 Prostate adenocarcinoma Ubiquitination N K192 Q15750 10454 TAB1 MAP3K7IP1 Bladder urothelial carcinoma Ubiquitination N K262 Q15750 10454 TAB1 MAP3K7IP1 Skin cutaneous melanoma Ubiquitination N K262 Q15750 10454 TAB1 MAP3K7IP1 Stomach adenocarcinoma Ubiquitination N K262 Q15750 10454 TAB1 MAP3K7IP1 Uterine corpus endometrial carcinoma Ubiquitination N K262 Q15750 10454 TAB1 MAP3K7IP1 Bladder urothelial carcinoma Ubiquitination N K264 Q15750 10454 TAB1 MAP3K7IP1 Skin cutaneous melanoma Ubiquitination N K264 Q15750 10454 TAB1 MAP3K7IP1 Stomach adenocarcinoma Ubiquitination N K264 Q15750 10454 TAB1 MAP3K7IP1 Uterine corpus endometrial carcinoma Ubiquitination N K264 Q15750 10454 TAB1 MAP3K7IP1 Breast invasive carcinoma Phosphorylation N S339 Q15750 10454 TAB1 MAP3K7IP1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S339 Q15750 10454 TAB1 MAP3K7IP1 Lung adenocarcinoma Phosphorylation N S339 Q15750 10454 TAB1 MAP3K7IP1 Brain cancer Phosphorylation N S378 Q15750 10454 TAB1 MAP3K7IP1 Thyroid carcinoma Phosphorylation N S378 Q15750 10454 TAB1 MAP3K7IP1 Lung squamous cell carcinoma O-linked glycosylation N S395 Q15750 10454 TAB1 MAP3K7IP1 Bladder urothelial carcinoma Phosphorylation N S423 Q15750 10454 TAB1 MAP3K7IP1 Brain lower grade glioma Phosphorylation N S423 Q15750 10454 TAB1 MAP3K7IP1 Bladder urothelial carcinoma Phosphorylation N T431 Q15750 10454 TAB1 MAP3K7IP1 Lung squamous cell carcinoma Phosphorylation N T431 Q15750 10454 TAB1 MAP3K7IP1 Lung squamous cell carcinoma Phosphorylation N S438 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Phosphorylation N S452 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Phosphorylation N S453 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Phosphorylation N S456 Q15750 10454 TAB1 MAP3K7IP1 Head and neck squamous cell carcinoma Phosphorylation N S457 Q15750 10454 TAB1 MAP3K7IP1 Stomach adenocarcinoma Phosphorylation N S469 Q15750 10454 TAB1 MAP3K7IP1 Mesothelioma Phosphorylation N S492 Q15750 10454 TAB1 MAP3K7IP1 Sarcoma Phosphorylation N S492 Q15750 10454 TAB1 MAP3K7IP1 Stomach adenocarcinoma Phosphorylation N S492 Q15910 2146 EZH2 KMT6 Kidney renal clear cell carcinoma Ubiquitination N K7 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K7 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K7 Q15910 2146 EZH2 KMT6 Kidney renal clear cell carcinoma Ubiquitination N K10 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K10 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K10 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Ubiquitination N K39 Q15910 2146 EZH2 KMT6 Stomach adenocarcinoma Ubiquitination N K39 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K39 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Ubiquitination N K61 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K61 Q15910 2146 EZH2 KMT6 Weaver syndrome O-linked glycosylation N S75 Q15910 2146 EZH2 KMT6 Weaver syndrome O-linked glycosylation N S76 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S76 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S212 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N S220 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S220 Q15910 2146 EZH2 KMT6 Bladder urothelial carcinoma Acetylation N K234 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Acetylation N K234 Q15910 2146 EZH2 KMT6 Bladder urothelial carcinoma Ubiquitination N K234 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K234 Q15910 2146 EZH2 KMT6 Non-Hodgkin's lymphoma Phosphorylation N T261 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T261 Q15910 2146 EZH2 KMT6 Bladder urothelial carcinoma Phosphorylation N S277 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S277 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Phosphorylation N T302 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Phosphorylation N T305 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Phosphorylation N T311 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Phosphorylation N T311 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T311 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Ubiquitination N K318 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K318 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Phosphorylation C T339 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N T339 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Phosphorylation N T339 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T339 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Acetylation N K348 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Acetylation N K348 Q15910 2146 EZH2 KMT6 Cervical adenocarcinoma Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Head and neck squamous cell carcinoma Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Cervical adenocarcinoma Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Head and neck squamous cell carcinoma Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Cervical adenocarcinoma Phosphorylation N S366 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S366 Q15910 2146 EZH2 KMT6 Lung squamous cell carcinoma Phosphorylation N T367 Q15910 2146 EZH2 KMT6 Lung squamous cell carcinoma Phosphorylation N T369 Q15910 2146 EZH2 KMT6 Lung squamous cell carcinoma Phosphorylation N S380 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T388 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N S408 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N S412 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K461 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K461 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K472 Q15910 2146 EZH2 KMT6 Breast cancer Phosphorylation N T487 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T487 Q15910 2146 EZH2 KMT6 Weaver syndrome Methylation N K510 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Ubiquitination N K569 Q15910 2146 EZH2 KMT6 Stomach adenocarcinoma Ubiquitination N K569 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K597 Q15910 2146 EZH2 KMT6 Stomach adenocarcinoma Ubiquitination N K602 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Ubiquitination N K629 Q15910 2146 EZH2 KMT6 Non-Hodgkin's lymphoma Ubiquitination N K634 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K634 Q15910 2146 EZH2 KMT6 Diffuse large B-cell lymphoma Phosphorylation N Y641 Q15910 2146 EZH2 KMT6 Non-Hodgkin's lymphoma Phosphorylation N Y641 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N Y641 Q15910 2146 EZH2 KMT6 Acute myeloid leukemia Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Chronic myelomonocytic leukemia Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Hepatocellular carcinoma Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Breast invasive carcinoma Ubiquitination N K713 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K713 Q15910 2146 EZH2 KMT6 Breast invasive carcinoma Phosphorylation N T718 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T718 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S729 Q15910 2146 EZH2 KMT6 Weaver syndrome Methylation N K735 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K735 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K735 P16615 488 ATP2A2 ATP2B Chronic hypoxic pulmonary hypertension lung tissue Serotonylation U 32116663 P49116 7182 NR2C2 TAK1 TR4 Cardiac hypertrophy macrophages Phosphorylation U 37443105 Q15910 2146 EZH2 KMT6 Clear cell renal cell carcinoma ccRCC tissues Ubiquitination U 37747077 Q15910 2146 EZH2 KMT6 Glioma tumor tissue Deubiquitination P 30425057 Q15910 2146 EZH2 KMT6 Prostate cancer tumor tissue Deubiquitination P 30622230 P49116 7182 NR2C2 TAK1 TR4 Cancer tumor tissue Deubiquitination U 35361778 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer tissues Polyubiquitination D 32895488 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer cell lines Poly(ADP-ribosyl)ation D 28925391 P16615 488 ATP2A2 ATP2B Pathological cardiac hypertrophy cardiomyocytes Deubiquitination D 36722348 Q15910 2146 EZH2 KMT6 Diabetic nephropathy renal tissues Glycosylation D 33609540 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma tumor tissue Tyrosine phosphorylation U Y990 37719369 P49116 7182 NR2C2 TAK1 TR4 Oral squamous cell carcinoma tumor tissue Threonine phosphorylation U T187 35051616 Q15750 10454 TAB1 MAP3K7IP1 Lung adenocarcinoma tumor tissues Serine phosphorylation P S438 35945223 Q15910 2146 EZH2 KMT6 Lung cancer lung cancer cells N-myristoylation U G2 34102285 Q15910 2146 EZH2 KMT6 Prostate cancer tumor tissue Serine phosphorylation U S21 34230470 Q15910 2146 EZH2 KMT6 Cancer tumor tissue Lysine methylation U K307 31693890 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer cell Threonine phosphorylation D T311 34775498 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer cell Arginine methylation U R342 34775498 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer tissues Threonine phosphorylation D T345 32895488 Q15910 2146 EZH2 KMT6 Psoriasis skin tissue Threonine phosphorylation U T345 32701505 Q15910 2146 EZH2 KMT6 Triple-negative breast cancer breast cancer tissues Threonine phosphorylation U T367 35992062 Q15910 2146 EZH2 KMT6 Triple-negative breast cancer tumor tissue Threonine phosphorylation P T416 31704972 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer tissues Threonine phosphorylation D T487 32895488 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma lung cancer tissues Threonine phosphorylation U T487 32483123 Q15910 2146 EZH2 KMT6 Prostate cancer tumor tissue Lysine methylation D K735 32619406 Q15910 2146 EZH2 KMT6 Pathological cardiac hypertrophy Ubiquitination U 32380038 P49116 7182 NR2C2 TAK1 TR4 Non-alcoholic fatty liver Autophosphorylation U 34689362 P16615 488 ATP2A2 ATP2B Heart failure Acetylation U K492 30786847 P16615 488 ATP2A2 ATP2B Heart failure Deacetylation D K492 30786847 Q15910 2146 EZH2 KMT6 Gallbladder cancer tumor tissue Ubiquitination A 30282996 Q15910 2146 EZH2 KMT6 Breast cancer/tumor/carcinoma Methylation D 3811872 Q15910 2146 EZH2 KMT6 Breast cancer/tumor/carcinoma Methylation D 23918806 P49116 7182 NR2C2 TAK1 TR4 Alzheimer's disease Phosphorylation C 23844119 P49116 7182 NR2C2 TAK1 TR4 Pathological cardiac hypertrophy Autophosphorylation U 35352799 Q15750 10454 TAB1 MAP3K7IP1 Pathological cardiac hypertrophy Ubiquitination U 35352799 P16615 488 ATP2A2 ATP2B Cardiomyopathy SUMOylation D K480 21900893 P16615 488 ATP2A2 ATP2B Cardiomyopathy SUMOylation D K585 21900893 Q15910 2146 EZH2 KMT6 HER2-positive breast cancer Serine phosphorylation U S21 37803297 Q15910 2146 EZH2 KMT6 Melanoma Serine phosphorylation U S21 26517694 Q15910 2146 EZH2 KMT6 Cancer Lysine methylation N K27 3868555;24367637 Q15910 2146 EZH2 KMT6 Malignant disease Lysine methylation P K27 24183969 Q15910 2146 EZH2 KMT6 Breast cancer Threonine phosphorylation U T311 29351847 Q15910 2146 EZH2 KMT6 Ovarian cancer Threonine phosphorylation U T311 29351847 Q15910 2146 EZH2 KMT6 Lung cancer Acetylation U K348 25800736 Q15910 2146 EZH2 KMT6 Breast cancer/tumor/carcinoma Threonine phosphorylation P T416 26279746 Q15910 2146 EZH2 KMT6 Breast cancer Threonine phosphorylation U T487 34381492 Q15910 2146 EZH2 KMT6 HER2-positive breast cancer Threonine phosphorylation U T487 37803297 Q15910 2146 EZH2 KMT6 Triple-negative breast cancer Threonine phosphorylation U T487 37803297